Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% | -47.06% | -.--% |
2019 | SalvaRx Evaluates Takeover Opportunities | CI |
2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
Chart calendar SalvaRx Group plc
Upcoming events on SalvaRx Group plc
No events available
Past events on SalvaRx Group plc
2019-09-26 09:06 am | Interim 2019 Earnings Release |
Past dividends on SalvaRx Group plc
2015-02-15 | 0.0133 GBP |
2014-11-25 | Bonus Payment 0.185 GBP |
Annual results
Fiscal Period | December | 2016 |
---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - |
EBITDA Million GBP | Released Forecast Spread | -1,61 -2,00 19.7% |
EBIT Million GBP | Released Forecast Spread | -1,61 -2,45 34.45% |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -2,48 -2,45 -1.06% |
Net income Million GBP | Released Forecast Spread | -2,04 -2,45 16.82% |
EPS GBP | Released Forecast Spread | -0,06 -0,07 10.71% |
Announcement Date | 30/06/17 |
Past sector events for SalvaRx Group plc
2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- SALV Stock
- Calendar SalvaRx Group plc